---
figid: PMC3262331__jbm-1-093f2
figlink: /pmc/articles/PMC3262331/figure/f2-jbm-1-093/
number: Figure 2
caption: 'Schematic signaling pathway mediated by the L-CBM complex in T and B lymphocytes.Notes:
  The L-CBM complex acts in the canonical NF-κB (p65/p50, cRel/p50) activation pathway
  mediated by IKKβ downstream of TCRs and BCRs. L-CBM also controls the JNK, particularly
  JNK2, activation pathway through antigen receptors, leading to c-JUN activation.
  Upon antigen receptor stimulation, PKCθ in T cells and PKCβ in B cells phosphorylate
  CARMA1 in the PRD region (see ), enabling the formation and membrane recruitment
  of the L-CBM complex. IKKβ positively and negatively regulates L-CBM signaling.
  These signaling events are regulated by the recruitment of signaling components
  to specific membrane domains, such as lipid rafts, after receptor triggering. In
  MZ B cells, L-CBM mediates signals for canonical NF-κB activation through TLR4-Myd88.
  L-CBM also mediates signals for noncanonical NF-κB (RelB/p52) activation mediated
  by NIK and IKKα downstream of the BAFF receptor (BAFF-R), which regulates the survival
  of MZ B cells.'
pmcid: PMC3262331
papertitle: L-CBM signaling in lymphocyte development and function.
reftext: Hiromitsu Hara, et al. J Blood Med. 2010;1:93-104.
pmc_ranked_result_index: '39481'
pathway_score: 0.9485111
filename: jbm-1-093f2.jpg
figtitle: 'Schematic signaling pathway mediated by the L-CBM complex in T and B lymphocytes.Notes:
  The L-CBM complex acts in the canonical NFKB (p65/p50, cRel/p50) activation pathway
  mediated by IKKB downstream of TCRs and BCRs'
year: '2010'
organisms: Homo sapiens
ndex: 29e25051-def6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3262331__jbm-1-093f2.html
  '@type': Dataset
  description: 'Schematic signaling pathway mediated by the L-CBM complex in T and
    B lymphocytes.Notes: The L-CBM complex acts in the canonical NF-κB (p65/p50, cRel/p50)
    activation pathway mediated by IKKβ downstream of TCRs and BCRs. L-CBM also controls
    the JNK, particularly JNK2, activation pathway through antigen receptors, leading
    to c-JUN activation. Upon antigen receptor stimulation, PKCθ in T cells and PKCβ
    in B cells phosphorylate CARMA1 in the PRD region (see ), enabling the formation
    and membrane recruitment of the L-CBM complex. IKKβ positively and negatively
    regulates L-CBM signaling. These signaling events are regulated by the recruitment
    of signaling components to specific membrane domains, such as lipid rafts, after
    receptor triggering. In MZ B cells, L-CBM mediates signals for canonical NF-κB
    activation through TLR4-Myd88. L-CBM also mediates signals for noncanonical NF-κB
    (RelB/p52) activation mediated by NIK and IKKα downstream of the BAFF receptor
    (BAFF-R), which regulates the survival of MZ B cells.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TRG
  - TRD
  - MAPK9
  - PRKCZ
  - TRA
  - MALT1
  - BCL10
  - TRAF6
  - TRB
  - PRKCA
  - MYD88
  - TNFRSF13C
  - PRKCD
  - IKBKB
  - CHUK
  - TLR4
  - TNFSF13B
  - PRKCB
  - PRKD3
  - JUN
  - CARD11
  - PRKCQ
  - BCR
  - NFKB1
  - PRKCI
  - REL
  - PRKCH
  - PRKCE
  - RELB
  - PRKCG
  - NR2C2
  - Cancer
genes:
- word: TCR/BCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: TCR/BCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: JNK2
  symbol: JNK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: TCR/BCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: MALT1
  symbol: MALT1
  source: hgnc_symbol
  hgnc_symbol: MALT1
  entrez: '10892'
- word: BCL10
  symbol: BCL10
  source: hgnc_symbol
  hgnc_symbol: BCL10
  entrez: '8915'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: TCR/BCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: MyD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: BAFF-R
  symbol: BAFFR
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF13C
  entrez: '115650'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: IKKB
  symbol: IKK-beta
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: IKKA
  symbol: IKK-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: TLR4
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: BAFF
  symbol: BAFF
  source: hgnc_alias_symbol
  hgnc_symbol: TNFSF13B
  entrez: '10673'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: C-JUN
  symbol: c-Jun
  source: hgnc_alias_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: CARMA1
  symbol: CARMA1
  source: hgnc_alias_symbol
  hgnc_symbol: CARD11
  entrez: '84433'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: TCR/BCR
  symbol: BCR
  source: hgnc_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: PKC6/B
  symbol: PKCB
  source: hgnc_prev_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: (p65/cRel/p50)(RelB/p52)
  symbol: c-Rel
  source: hgnc_alias_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: (RelB/p52)
  symbol: RELB
  source: hgnc_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: TAK1
  symbol: TAK1
  source: hgnc_alias_symbol
  hgnc_symbol: NR2C2
  entrez: '7182'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
